CAPD versus haemodialysis: A comparison in the same patients

Morduchowicz, G.; Winkler, J.; Boner, G

doi:10.1007/bf02550127

Cited by 2 publications

(2 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hospitalisation is a very important indicator of morbidity in assessment of the peritoneal dialysis program, such as in haemodialysis. There are many publications comparing hospitalisations between PD and HD, but there are few and small studies in this aspect between patients who started PD as a substitutive therapy and patients treated sequentially with haemodialysis and peritoneal dialysis [ 54 – 56 ]. In our study period, we did not observe any statistical differences in admissions nor number of hospitalizations days per patients/year between both groups.…”

Section: Discussionmentioning

confidence: 99%

Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment

Barone¹,

Cámpora²,

Gimenez³

et al. 2014

International Journal of Nephrology

View full text Add to dashboard Cite

For renal replacement therapy, overall survival is more important than the choice of currently available individual therapy. Objectives. To compare patients and technique survival on peritoneal dialysis as first treatment (PDF) versus after previous haemodialysis (HDPD) and other indicators of follow-up. Methods. We prospectively studied 110 incident patients, during the period from August 4, 1993, to June 30, 2012, for patients and technique survival (Kaplan-Meier) (log rank P < 0.05). Results. Groups: (A) PDF: 37 patients, 24 females, age: 52.2 ± 14.9 years old, time at risk: 2123 patient-months (p/m), mean: 57 ± 42 months; (B) HDPD: 73 patients, 42 females, age: 52.45 ± 14.7 years old, time in haemodialysis: 3569.2 (p/m), range: 3–216 months, mean: 49 ± 45 months, time at risk in PD: 3700 (p/m), mean: 51 ± 49 months. Patients' survival: (A) PDF: 100%, 76.6%, 65.6%, and 19.7%; (B) HDPD: 95.4%, 65.6%, 43%, and 43% at 12, 60, 120, and 144 months, respectively, P = 0.34. Technique: (A) PDF: 100%, 90%, 59.8%, and 24%; (B) HDPD: 94%, 75%, 32%, and 32% at 12, 60, 120, and 144 months, respectively, P = 0.40. Conclusions. Comparable patient and technique survival were observed. Peritoneal dialysis enables a greater extension of renal replacement therapy for patients with serious difficulties continuing with haemodialysis.

show abstract

Section: Discussionmentioning

confidence: 99%

Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment

Barone¹,

Cámpora²,

Gimenez³

et al. 2014

International Journal of Nephrology

View full text Add to dashboard Cite

show abstract

“…Approximately 60% of Medicare's ESRD bud get. in the United States, is spent on the cost of morbidity and hospitalizations [1], Reports of hospitalization rates among ESRF patients have used different methodologies [2][3][4], Some series included only hospitalizations due to dialysis complications [2], others included only accessrelated hospitalizations [1. 4] and in others there is no specification [3], Therefore, we performed a 1-year pro spective study of all hospitalizations of the ESRF patients treated at our institution.…”

Section: Introductionmentioning

confidence: 99%

Hospitalizations in Dialysis End-Stage Renal Failure Patients

Morduchowicz

Boner²

1996

Nephron

View full text Add to dashboard Cite

The cost of treating end-stage renal failure (ESRF) patients includes not only the cost of dialysis and related medications but also the cost of hospitalizing these patients. This study examines the hospitalization rate in ESRF patients. During 1993,126 ESRF patients were dialyzed in our institution. All hospitalizations were recorded. The study included 213 hospitalizations in 91 patients (mean 1.7 hospitalizations/patient/year). The mean length of each hospitalization was 4.8 ± 5.6 days. Seventy-six hospitalizations were for 1 day. Access (vascular and peritoneal) was the main cause (31%), but these admissions accounted for only 8.7% of days in hospital, while cardiovascular and infections represented 38 and 29%, respectively. No correlation was found between type of dialysis, sex and erythropoietin use and hospitalization rate. 46.5% of admissions were uremia-dialysis related but they accounted for only 30% of the days in hospital. Age and the presence of diabetes mellitus correlated with hospitalization not related to uremia and/or dialysis. Thus, most of the time spent in hospital was secondary to conditions unrelated to uremia and/or dialysis. Efforts should be made to reduce the dialysis-uremia-related hospitalizations and thus reduce the cost of treatment.

show abstract

CAPD versus haemodialysis: A comparison in the same patients

Cited by 2 publications

References 8 publications

Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment

Peritoneal Dialysis as a First versus Second Option after Previous Haemodialysis: A Very Long-Term Assessment

Hospitalizations in Dialysis End-Stage Renal Failure Patients

Contact Info

Product

Resources

About